Cardiac Biotech Solutions Inc. (CBSC)

Cardiac Biotech Solutions Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2018	FY 2017
Period Ending	Dec 31, 2018	Mar 31, 2018	Mar 31, 2017
Cash & Equivalents	0.01	0	0.01
Cash & Short-Term Investments	0.01	0	0.01
Cash Growth	-	-62.63%	-
Receivables	0.01	0.01	0.01
Inventory	0.02	0.01	0.02
Total Current Assets	0.04	0.03	0.04
Property, Plant & Equipment	0	0.01	0
Other Intangible Assets	0.02	0.02	0.02
Total Assets	0.06	0.06	0.07
Accounts Payable	0.18	0.15	0.15
Accrued Expenses	0.84	0.61	0.19
Other Current Liabilities	0.43	0.51	0.25
Total Current Liabilities	1.44	1.27	0.59
Total Liabilities	1.44	1.27	0.59
Common Stock	0.06	0.06	0.06
Additional Paid-In Capital	0.51	0.44	0
Retained Earnings	-1.96	-1.72	-0.59
Total Common Equity	-1.39	-1.22	-0.53
Shareholders' Equity	-1.38	-1.21	-0.52
Total Liabilities & Equity	0.06	0.06	0.07
Net Cash (Debt)	0.01	0	0.01
Net Cash Growth	-	-62.63%	-
Net Cash Per Share	0.00	0.00	0.00
Filing Date Shares Outstanding	58.59	58.59	57.11
Total Common Shares Outstanding	58.59	58.59	57.11
Working Capital	-1.4	-1.24	-0.54
Book Value Per Share	-0.02	-0.02	-0.01
Tangible Book Value	-1.41	-1.25	-0.55
Tangible Book Value Per Share	-0.02	-0.02	-0.01
Machinery	0.01	0.01	0

Updated Mar 5, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.